PRNP mutations initially generate an alternatively misfolded PrP species that dissuades prion replication
This study reveals that PRNP mutations initially generate a protective, alternatively misfolded PrP species (PrPAM) that resists prion replication, offering a potential explanation for the late-onset nature of genetic prion diseases despite the presence of mutations from birth.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Prion diseases are a rare but devastating group of disorders that affect the brains of humans and animals. These illnesses, which include conditions like Creutzfeldt-Jakob disease in people and mad cow disease in cattle, are caused by a rogue version of a normal protein called the prion protein. In a healthy brain, this protein sits on the surface of nerve cells and performs its duties without issue. However, when it misfolds—twisting into a strange, rigid shape—it becomes toxic and infectious. This malformed version acts like a template, forcing nearby healthy proteins to twist into the same bad shape, creating a chain reaction that destroys brain tissue. While some people catch these diseases from eating contaminated meat or through medical accidents, others inherit a genetic mutation that makes their own proteins prone to misfolding. For decades, scientists have struggled to understand exactly how these genetic mutations trigger the disease, especially since people carrying the mutation are born with it but often do not show symptoms until they are much older.
A team of researchers set out to solve this mystery by looking at the very first moments when a mutant protein begins to go wrong. They focused on two specific genetic changes, known as D178N and E200K, which are common causes of inherited prion disease. To observe these events without the noise of a whole living animal, they used cultured brain cells that had been stripped of their own natural prion proteins. Into these empty cells, they introduced the mutant versions of the prion protein found in bank voles, a small rodent whose protein is unusually good at forming prions. The researchers expected to see the mutant proteins immediately turning into the infectious, disease-causing form. Instead, they discovered something unexpected: the mutations caused the proteins to fold into a different kind of misshapen structure entirely. The researchers named this new form PrPAM.
This newly discovered PrPAM is distinct from the deadly prion. It is a clump of protein that resists being broken down by certain enzymes, specifically a digestive enzyme called thermolysin, but it does not possess the ability to infect other cells or spread the disease. In fact, the presence of PrPAM seems to act as a shield. When the researchers tried to infect these cells with actual prions, the cells containing the mutant proteins and their PrPAM clumps largely resisted infection. They remained healthy while cells with normal proteins quickly became infected. This suggests that the genetic mutation does not immediately create a disease seed; rather, it first creates a protective, misfolded version of the protein that blocks the formation of the truly dangerous kind.
The study also examined whether this protective barrier holds up over time or if it can be broken by drugs. The researchers treated the cells with small molecules known to stop prion diseases in other contexts. These drugs successfully reduced the levels of the infectious prion in infected cells, but they had no effect on the levels of PrPAM in the mutant cells. This confirmed that PrPAM is a separate entity, not just a step on the road to the infectious form. Furthermore, when the team looked at young mice that carried the same genetic mutations, they found these same PrPAM clumps in the animals' brains long before the mice ever showed signs of illness. The protective clumps were there for months, perhaps years, before the disease eventually took hold.
One of the most surprising findings came from testing a genetic change known to protect people against prion disease. Scientists had long believed that this protective change worked by stopping proteins from misfolding in the first place. However, when the researchers added this protective change to the mutant proteins in their cells, the amount of PrPAM actually increased. The protective change did not stop the formation of the misfolded clump; instead, it seemed to encourage it. This suggests that the protective change works by pushing the protein into this harmless, misfolded state, effectively trapping it there so it cannot transform into the infectious version.
The researchers concluded that the story of genetic prion disease is more complex than a simple switch flipping from healthy to sick. The genetic mutations present from birth initially generate this alternative, misfolded species that acts as a barrier against the disease. This explains why people with these mutations can live for decades without symptoms; their bodies are constantly producing a version of the protein that resists becoming infectious. Eventually, however, this protective system fails, and the infectious prion takes over, leading to the disease. While the study does not yet explain exactly how or why this protection eventually breaks down, it offers a new perspective on the early stages of these fatal disorders. By identifying this intermediate, protective state, the research opens a new path for understanding how the disease begins and perhaps how to keep the protective barrier intact for longer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.